Growing demand for Go-less

3 June 2013

Frutarom Health in Switzerland has reported an increased demand for Go-Less, its natural ingredient targeting urinary incontinence in adults.
A number of supplements for urinary incontinence containing Go-Less recently launched in Europe and North America. Frutarom Health expects strong sales growth from this ingredient.
With 200 million people worldwide affected, urinary incontinence in adults is becoming more widespread as older populations continue to represent a larger global demographic segment, according to a 2012 article in Nonwovens Industry magazine.

An overwhelming majority of sufferers are women -- approximately 75-80% -- but more men are affected by the condition than ever before. Moreover, increasingly younger people are being afflicted.

"The market for urinary incontinence remedies in adults is growing fast, especially in the U.S. and Western Europe where active seniors and even younger sufferers are seeking natural products that are effective and do not interfere with their lifestyle," said Patricia Maureira, product manager of the LifeLine at Frutarom Health. "Frutarom has seen an increasing market interest in Go-Less in the US and West and Eastern Europe during the first quarter of this year alone."

SEVURIN is one new all-natural supplement that contains Frutarom's Go-Less. It is marketed by Hilton Pharma, Italy, exclusively to pharmacies, para-pharmacies, and top herbalists in Italy. SEVURIN helps to combat female incontinence -- in specific, light incontinence in women -- and helps to promote normal function of the urinary system.

SEVURIN contains a proprietary blend of Go-Less consisting of EFLA® 940, a natural ingredient derived from pumpkin seed, specifically Cucurbita pepo L. (var. styriaca) seeds, and SoyLife®40%, isoflavones from soy germ (Glycine max L.). This combination provides a natural support in the treatment of micturition disorders, with pre-clinical, in vitro research and clinical studies supporting its safety and efficacy in addressing the cause of overactive bladder and urinary incontinency as well as reducing its symptoms.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.